Overview

Phase I/II Dose Ranging CHRONSEAL® Study in Venous Leg Ulcers

Status:
Unknown status
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate if the investigational medicinal product CHRONSEAL intended for future treatment of chronic venous leg ulcers is safe and tolerated and if it has an ulcer size reduction effect when administered to individuals suffering from venous leg ulcers.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Kringle Pharma Europe AB
Collaborator:
Kringle Pharma, Inc.